BX-517

CAS No. 850717-64-5

BX-517( BX-517 | BX 517 | BX517 | PDK1 inhibitor2 )

Catalog No. M17615 CAS No. 850717-64-5

BX-517 is a potent and selective inhibitor of PDK1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 58 In Stock
10MG 80 In Stock
25MG 140 In Stock
50MG 260 In Stock
100MG 410 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BX-517
  • Note
    Research use only, not for human use.
  • Brief Description
    BX-517 is a potent and selective inhibitor of PDK1.
  • Description
    BX-517, also known as PDK1 inhibitor2, is a potent and selective PDK1 inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BX-517 | BX 517 | BX517 | PDK1 inhibitor2
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Retinoid Receptor
  • Recptor
    PDK1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    850717-64-5
  • Formula Weight
    282.3
  • Molecular Formula
    C15H14N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 27 mg/mL; 95.64 mM
  • SMILES
    O=C(Nc1cc2c(NC(=O)/C/2=C(\c2ccc[nH]2)/C)cc1)N
  • Chemical Name
    (Z)-N-(3-(1-(1H-pyrrol-2-yl)ethylidene)-2-hydroxy-3H-indol-5-yl)carbamimidic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Islam I, et al. Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: optimization of BX-517. Bioorg Med Chem Lett. 2007 Jul 15;17(14):3819-25.
molnova catalog
related products
  • AC-55649

    AC-55649 is a potent and highly isoform-selective agonist of the human RARβ2 receptor, characterized by a pEC50 of 6.9.

  • AM580

    AM580 is a retinoic acid receptor agonist that is selective for RARα( IC50 : 8 nM ).

  • Bexarotene

    Bexarotene is a retinoid specifically selective for retinoid X receptors, used as an oral antineoplastic agent in the treatment of cutaneous T-cell lymphoma.